A citation-based method for searching scientific literature


List of co-cited articles
1318 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
56

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
G J Klapstein, R S Fisher, H Zanjani, C Cepeda, E S Jokel, M F Chesselet, M S Levine. J Neurophysiol 2001
246
52

The corticostriatal pathway in Huntington's disease.
Carlos Cepeda, Nanping Wu, Véronique M André, Damian M Cummings, Michael S Levine. Prog Neurobiol 2007
232
49

Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease.
Benjamin R Miller, Adam G Walker, Anand S Shah, Scott J Barton, George V Rebec. J Neurophysiol 2008
87
44

Altered information processing in the prefrontal cortex of Huntington's disease mouse models.
Adam G Walker, Benjamin R Miller, Jenna N Fritsch, Scott J Barton, George V Rebec. J Neurosci 2008
67
41

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
38

Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.
Damian M Cummings, Véronique M André, Besim O Uzgil, Steven M Gee, Yvette E Fisher, Carlos Cepeda, Michael S Levine. J Neurosci 2009
120
37

Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.
Carlos Cepeda, Raymond S Hurst, Christopher R Calvert, Elizabeth Hernández-Echeagaray, Oanh K Nguyen, Emily Jocoy, Lindsey J Christian, Marjorie A Ariano, Michael S Levine. J Neurosci 2003
253
35

Differential loss of striatal projection neurons in Huntington disease.
A Reiner, R L Albin, K D Anderson, C J D'Amato, J B Penney, A B Young. Proc Natl Acad Sci U S A 1988
740
34

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
34

Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.
Prasad R Joshi, Nan-Ping Wu, Véronique M André, Damian M Cummings, Carlos Cepeda, John A Joyce, Jeffrey B Carroll, Blair R Leavitt, Michael R Hayden, Michael S Levine,[...]. J Neurosci 2009
129
32

Impaired glutamate uptake in the R6 Huntington's disease transgenic mice.
J C Liévens, B Woodman, A Mahal, O Spasic-Boscovic, D Samuel, L Kerkerian-Le Goff, G P Bates. Neurobiol Dis 2001
217
31

Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Liliana B Menalled, Jessica D Sison, Ioannis Dragatsis, Scott Zeitlin, Marie-Françoise Chesselet. J Comp Neurol 2003
337
31

Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.
G A Laforet, E Sapp, K Chase, C McIntyre, F M Boyce, M Campbell, B A Cadigan, L Warzecki, D A Tagle, P H Reddy,[...]. J Neurosci 2001
204
29

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
587
29

Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.
R J Carter, L A Lione, T Humby, L Mangiarini, A Mahal, G P Bates, S B Dunnett, A J Morton. J Neurosci 1999
696
28

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
443
28


NMDA receptor function in mouse models of Huntington disease.
C Cepeda, M A Ariano, C R Calvert, J Flores-Hernández, S H Chandler, B R Leavitt, M R Hayden, M S Levine. J Neurosci Res 2001
208
26

Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice.
Xiaofeng Gu, Chenjian Li, Weizheng Wei, Victor Lo, Shiaoching Gong, Shi-Hua Li, Takuji Iwasato, Shigeyoshi Itohara, Xiao-Jiang Li, Istvan Mody,[...]. Neuron 2005
173
26

Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse.
B R Miller, J L Dorner, M Shou, Y Sari, S J Barton, D R Sengelaub, R T Kennedy, G V Rebec. Neuroscience 2008
211
26

Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.
P F Behrens, P Franz, B Woodman, K S Lindenberg, G B Landwehrmeyer. Brain 2002
232
25

Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease.
M S Levine, G J Klapstein, A Koppel, E Gruen, C Cepeda, M E Vargas, E S Jokel, E M Carpenter, H Zanjani, R S Hurst,[...]. J Neurosci Res 1999
257
25

Ascorbate treatment attenuates the Huntington behavioral phenotype in mice.
George V Rebec, Scott J Barton, Ann M Marseilles, Kristin Collins. Neuroreport 2003
68
25


Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
L A Raymond, V M André, C Cepeda, C M Gladding, A J Milnerwood, M S Levine. Neuroscience 2011
200
25

The functional anatomy of basal ganglia disorders.
R L Albin, A B Young, J B Penney. Trends Neurosci 1989
23

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
S W Davies, M Turmaine, B A Cozens, M DiFiglia, A H Sharp, C A Ross, E Scherzinger, E E Wanker, L Mangiarini, G P Bates. Cell 1997
23

Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study.
Y P Deng, R L Albin, J B Penney, A B Young, K D Anderson, A Reiner. J Chem Neuroanat 2004
144
23

Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease.
Damian M Cummings, Austen J Milnerwood, Glenn M Dallérac, Verina Waights, Jacki Y Brown, Sarat C Vatsavayai, Mark C Hirst, Kerry P S J Murphy. Hum Mol Genet 2006
88
22

Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.
K P Murphy, R J Carter, L A Lione, L Mangiarini, A Mahal, G P Bates, S B Dunnett, A J Morton. J Neurosci 2000
286
22

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.
J G Hodgson, N Agopyan, C A Gutekunst, B R Leavitt, F LePiane, R Singaraja, D J Smith, N Bissada, K McCutcheon, J Nasir,[...]. Neuron 1999
635
22

Differential electrophysiological changes in striatal output neurons in Huntington's disease.
Véronique M André, Carlos Cepeda, Yvette E Fisher, My Huynh, Nora Bardakjian, Sumedha Singh, X William Yang, Michael S Levine. J Neurosci 2011
96
22

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.
J H Cha, C M Kosinski, J A Kerner, S A Alsdorf, L Mangiarini, S W Davies, J B Penney, G P Bates, A B Young. Proc Natl Acad Sci U S A 1998
412
20

Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease.
Jenelle L Dorner, Benjamin R Miller, Scott J Barton, Tyler J Brock, George V Rebec. Behav Brain Res 2007
67
20

Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease.
Rona K Graham, Mahmoud A Pouladi, Prasad Joshi, Ge Lu, Yu Deng, Nan-Ping Wu, Bryan E Figueroa, Martina Metzler, Véronique M André, Elizabeth J Slow,[...]. J Neurosci 2009
94
20

Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice.
Austen J Milnerwood, Clare M Gladding, Mahmoud A Pouladi, Alexandra M Kaufman, Rochelle M Hines, Jamie D Boyd, Rebecca W Y Ko, Oana C Vasuta, Rona K Graham, Michael R Hayden,[...]. Neuron 2010
343
20


Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.
Melinda M Zeron, Oskar Hansson, Nansheng Chen, Cheryl L Wellington, Blair R Leavitt, Patrik Brundin, Michael R Hayden, Lynn A Raymond. Neuron 2002
451
19

Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect.
Michael S Levine, Carlos Cepeda, Miriam A Hickey, Sheila M Fleming, Marie-Françoise Chesselet. Trends Neurosci 2004
127
19

Glutamate uptake is reduced in prefrontal cortex in Huntington's disease.
Bjørnar Hassel, Shoshi Tessler, Richard L M Faull, Piers C Emson. Neurochem Res 2008
95
19

Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease.
R L Albin, A Reiner, K D Anderson, L S Dure, B Handelin, R Balfour, W O Whetsell, J B Penney, A B Young. Ann Neurol 1992
261
19

Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.
M A Hickey, A Kosmalska, J Enayati, R Cohen, S Zeitlin, M S Levine, M-F Chesselet. Neuroscience 2008
147
19

Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms.
Carlos Cepeda, Damian M Cummings, Véronique M André, Sandra M Holley, Michael S Levine. ASN Neuro 2010
61
21

Dysfunctional behavioral modulation of corticostriatal communication in the R6/2 mouse model of Huntington's disease.
S Lee Hong, Desirée Cossyleon, Wajeeha A Hussain, Lauren J Walker, Scott J Barton, George V Rebec. PLoS One 2012
43
30

Striatal potassium channel dysfunction in Huntington's disease transgenic mice.
Marjorie A Ariano, Carlos Cepeda, Christopher R Calvert, Jorge Flores-Hernández, Elizabeth Hernández-Echeagaray, Gloria J Klapstein, Scott H Chandler, Neil Aronin, Marian DiFiglia, Michael S Levine. J Neurophysiol 2005
82
17

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.
R Luthi-Carter, A Strand, N L Peters, S M Solano, Z R Hollingsworth, A S Menon, A S Frey, B S Spektor, E B Penney, G Schilling,[...]. Hum Mol Genet 2000
566
17

Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.
Carlos Cepeda, Amaal J Starling, Nanping Wu, Oanh K Nguyen, Besim Uzgil, Takahiro Soda, Veronique M André, Marjorie A Ariano, Michael S Levine. J Neurosci Res 2004
102
17



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.